Reacción #91297

ord-c10ee6611019421dbe187f95e7e87b03

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    Otroto react sequentially in the same manner as in Steps A and B of Example 1

Procedimiento

3-Chloromethyl-2-cyclopentylsulfanyl-6-methyl-pyridine (35 mg, 0.15 mmol) obtained in Step C of Preparation Example 36 and 3-(3-chloro-4-hydroxy-phenyl)-propionic acid ethyl ester (36 mg, 0.17 mmol) obtained in Step C of Preparation Example 42 were used to react sequentially in the same manner as in Steps A and B of Example 1 to obtain the title compound (30 mg, 58%).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US09447044B2uspto-grants-2016_09